II. Criteria

  1. Asymptomatic on most days without interference with normal activity
  2. Occasional exacerbations (Less than twice/week)
    1. Exacerbations are brief (hours to days)
    2. Nighttime exacerbations are 2 or less times monthly
    3. Short-acting Beta Agonist (e.g. Albuterol) use 2 or less times weekly
    4. Oral Corticosteroids required 0-1 times per year
  3. Normal Pulmonary Function Test between exacerbations
    1. FEV1 or PEF >80% predicted
    2. FEV1 to FVC ratio normal (>85% for age 5-19 years, >80% for age 20-39 years, >75% for age 40-59, then >70%)
    3. PEF Variability <20%

III. Management

  1. See Asthma Stepped Care
  2. No daily medications necessary
  3. Inhaled short acting Beta agonist as needed
  4. If beta agonist use more than twice per week:
    1. Step-up to Mild Persistent Asthma Management
    2. Consider long-term control (Inhaled Corticosteroids)
  5. Asthma Education

IV. References

  1. Park (2017) Asthma Updates, Mayo Clinical Reviews, Rochester, MN
  2. (1997) Management of Asthma, NIH 97-4053
  3. (1995) Global Strategy for Asthma, NIH 95-3659
  4. Kalister (2001) West J Med 174:415-20 [PubMed]
  5. Kemp (2001) Am Fam Physician 63(7):1341-54 [PubMed]

Images: Related links to external sites (from Bing)

Related Studies

Ontology: Mild intermittent asthma (C1960045)

Concepts Disease or Syndrome (T047)
ICD10 J45.2 , J45.20
SnomedCT 427679007
English Mild intermittent asthma, Mild intermittent asthma (disorder), mild intermittent asthma (diagnosis), mild intermittent asthma, Mild intermittent asthma NOS
Spanish asma leve intermitente (trastorno), asma leve intermitente